# Rallybio Corporation (RLYB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RLYB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 878.5K | $ -9.19M | $ -30.53M | $ 176.0K | $ 57.96M |
| 2024 | $ 668.5K | $ -60.73M | $ -51.80M | $ 154.0K | $ 61.65M |
| 2023 | $ 246.5K | $ -80.62M | $ -65.18M | $ 392.0K | $ 106.18M |
| 2022 | $ 0 | $ -74.46M | $ -64.05M | $ 555.0K | $ 169.32M |
| 2021 | $ 0 | $ -55.88M | $ -54.52M | $ 0 | $ 175.60M |
| 2020 | $ 0 | $ -33.69M | $ -28.25M | $ 0 | $ 136.00M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.07 |
| Current Ratio | 14.50 |

## Other views

- [Metrics](https://sponda.capital/en/RLYB.md)
- [Charts](https://sponda.capital/en/RLYB/charts.md)
- [Compare](https://sponda.capital/en/RLYB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.